New-onset autoimmune thyroid disease following COVID-19.

IF 1.6 Q3 ALLERGY Asia Pacific Allergy Pub Date : 2024-08-01 Epub Date: 2024-05-30 DOI:10.5415/apallergy.0000000000000145

Öner Özdemir

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

COVID-19 后新发自身免疫性甲状腺疾病。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Asia Pacific Allergy ALLERGY-

CiteScore

2.50

自引率

5.90%

发文量

期刊介绍： Asia Pacific Allergy (AP Allergy) is the official journal of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI). Although the primary aim of the journal is to promote communication between Asia Pacific scientists who are interested in allergy, asthma, and clinical immunology including immunodeficiency, the journal is intended to be available worldwide. To enable scientists and clinicians from emerging societies appreciate the scope and intent of the journal, early issues will contain more educational review material. For better communication and understanding, it will include rational concepts related to the diagnosis and management of asthma and other immunological conditions. Over time, the journal will increase the number of original research papers to become the foremost citation journal for allergy and clinical immunology information of the Asia Pacific in the future.

期刊最新文献

Anti-IL-4Rα monoclonal antibody (CM310) in patients with chronic rhinosinusitis with nasal polyps (CROWNS-2): Rationale and design of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Food-dependent exercise-induced anaphylaxis (FDEIA) suspected triggered by lipid transfer protein in a Chinese child: A case report. From tumor to tolerance: A comprehensive review of immune checkpoint inhibitors and immune-related adverse events. New-onset autoimmune thyroid disease following COVID-19. Identification of cross-reactive IgE-binding proteins from Philippine allergenic grass pollen extracts.